Stopping aspirin in older adults with stable heart disease
Part of Heart & circulation clinical trials.
This trial tests whether older adults with stable heart disease can safely stop taking daily aspirin after two years without increasing the risk of heart attack or stroke. It may help reduce the side effects of long-term aspirin use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have had a heart attack, a heart stent, or bypass surgery more than 2 years ago.
- You have not had a heart attack, stroke, or another stent procedure since that time.
- You currently take low-dose aspirin (150 mg or less daily).
- You have not had a stroke or a stent in the left main artery of your heart, and you do not need blood thinners or other antiplatelet drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether daily aspirin is safe and effective for people who have stable (chronic) coronary artery disease but cannot have procedures to open blocked arteries. It may help reduce future heart problems, while also checking for side effects and risks from aspirin.
This study compares two different daily doses of aspirin (50 mg vs 100 mg) when taken with a standard blood thinner (P2Y12 inhibitor) after getting a heart stent. It aims to see if a lower aspirin dose works just as well with fewer side effects.
This study tests whether it is safe to stop taking aspirin after getting a CH-VAD heart pump, which helps pump blood for people with advanced heart failure. If you are taking aspirin to prevent blood clots, this trial will help doctors learn if you can stop it.
This study compares two blood-thinning medicines, aspirin and clopidogrel, to see which is better at preventing future heart problems in people with chronic coronary artery disease. If you have had a heart attack or unstable angina at least 6 months ago, this trial may help you understand an additional option for your heart health.
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
This trial studies whether taking your daily aspirin in the morning or at bedtime changes heart and circulation outcomes. It is meant to see if timing matters for people who already take aspirin every day.
Hear when a new Ischemic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.